Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keshav Goel

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2026
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)Adam Barsouk, Alec Heidlauf, Keshav Goel, et al.
ACS Nano|February 14, 2022
Nanoengineered Sprayable Therapy for Treating Myocardial InfarctionMarcelo Muñoz, Cagla Eren Cimenci, Keshav Goel, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2024
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinibAdam Barsouk, Omar Elghawy, Alec Heidlauf, et al.
Journal of Neuro-Oncology|September 7, 2025
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgeryJennifer C Hall, Keshav Goel, Yulia Lozko, et al.
Neurology|December 6, 2024
Outcome of Surgery for Hypothalamic Hamartoma-Related Epilepsy: A Systematic Review and Individual Participant Data Meta-AnalysisFarbod Niazi, Keshav Goel, Jia-Shu Chen, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2026
Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)Adam Barsouk, Alec Heidlauf, Keshav Goel, et al.
ACS Nano|February 14, 2022
Nanoengineered Sprayable Therapy for Treating Myocardial InfarctionMarcelo Muñoz, Cagla Eren Cimenci, Keshav Goel, et al.
Lung Cancer (Amsterdam, Netherlands)|August 13, 2024
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinibAdam Barsouk, Omar Elghawy, Alec Heidlauf, et al.
Journal of Neuro-Oncology|September 7, 2025
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgeryJennifer C Hall, Keshav Goel, Yulia Lozko, et al.
Neurology|December 6, 2024
Outcome of Surgery for Hypothalamic Hamartoma-Related Epilepsy: A Systematic Review and Individual Participant Data Meta-AnalysisFarbod Niazi, Keshav Goel, Jia-Shu Chen, et al.
Pageof 4